Hypogonadism Completed Phase 3 Trials for Metformin (DB00331)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02514629Testosterone, Metformin, or Both, for Hypogonadism in Obese MalesTreatment